Karen L. Smith - Director at Sangamo Therapeutics, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SGMO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Karen L. Smith since 7/17/2023

Holdings reported by Karen L. Smith for Sangamo Therapeutics, Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 77.1 K $46.3 K $0.60 Jun 4, 2024 Direct
Stock Option (Right to Buy) 50 K Jun 4, 2024 Direct Common Stock

Transactions reported by Karen L. Smith for Sangamo Therapeutics, Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership